
An RSV vaccine developed by Pfizer provides safe and effective protection in both seniors and newborns, clinical trial results show. The vaccine is 86% effective in protecting older adults against RSV infections severe enough to cause three or more symptoms, according to findings published April 5 in the New England Journal of Medicine. And the… read on > read on >